Cost-effectiveness of denosumab for high-risk postmenopausal women with osteoporosis in Thailand.
Conclusions. In Thailand, denosumab offers a cost-effective osteoporosis treatment option versus no pharmacologic treatment in postmenopausal women at high risk of fracture.
PMID: 32063082 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: Calcium | Economics | Health Management | Orthopaedics | Osteoporosis | Study | Thailand Health | Vitamin D | Vitamins | Women | Xgeva